A novel Golgi protein (GOLPH2)-regulated oncolytic adenovirus exhibits potent antitumor efficacy in hepatocellular carcinoma. - Wikidata - awgldk - TriplyDB

A novel Golgi protein (GOLPH2)-regulated oncolytic adenovirus exhibits potent antitumor efficacy in hepatocellular carcinoma.

A novel Golgi protein (GOLPH2)-regulated oncolytic adenovirus exhibits potent antitumor efficacy in hepatocellular carcinoma.

http://www.wikidata.org/entity/Q35955387

about

Targeting adeno-associated virus and adenoviral gene therapy for hepatocellular carcinoma Oncolytic viruses against cancer stem cells: A promising approach for gastrointestinal cancer A novel oncolytic adenovirus based on simian adenovirus serotype 24 Cypermethrin Induces Macrophages Death through Cell Cycle Arrest and Oxidative Stress-Mediated JNK/ERK Signaling Regulated Apoptosis GP73-regulated oncolytic adenoviruses possess potent killing effect on human liver cancer stem-like cells.Enhanced antitumor effect of combining TRAIL and MnSOD mediated by CEA-controlled oncolytic adenovirus in lung cancer.Cellular and molecular targets for the immunotherapy of hepatocellular carcinoma.GOLPH2-regulated oncolytic adenovirus, GD55, exerts strong killing effect on human prostate cancer stem-like cells in vitro and in vivo.Combination of oncolytic adenovirus and luteolin exerts synergistic antitumor effects in colorectal cancer cells and a mouse model.Association of GOLPH2 expression with survival in non-small-cell lung cancer: clinical implications and biological validation.Oncolytic Adenoviruses in Gastrointestinal Cancers.The Continued Promise and Many Disappointments of Oncolytic Virotherapy in Gastrointestinal Malignancies.Oncolytic virotherapy in upper gastrointestinal tract cancers.Research progress on GP73 in malignant tumors

P2860

Q26772315-32B6808B-DCA5-43A0-8256-191806877BF0 Q28078939-942BFB7A-E2A3-4E70-80FF-4E41BF78A1A5 Q33688856-56221C50-23BA-487B-BD46-A2D33F14CEFD Q37050663-1CBE175B-5E6F-442D-9C9B-B7D7FFC3BD67 Q37301817-223962DB-AAA4-4B03-B26E-3029288E688F Q38778137-289B2C1B-F0F1-4C71-BFA2-576EA8BC6EE8 Q39358916-25EB112D-910A-4466-AB2F-3CDBD6731AA4 Q40062992-1E4E4DC1-1300-421D-B472-281E2CDCA18A Q47609998-356F068E-B851-4004-A33B-6F89F4700D5E Q47843737-B3D45ED9-9ADC-449C-BC5A-B759D53B5B7F Q52726850-655CB27F-CB5C-4E07-AD31-00FDE41F7EFA Q52769266-6645BE94-E806-4BE8-BD67-85E1DBEA95FF Q54242367-4780A07C-7034-434B-8F3F-65BE9CD9F539 Q58694506-5C501AFD-1BFB-4652-9972-912B80AF733E

P2860

A novel Golgi protein (GOLPH2)-regulated oncolytic adenovirus exhibits potent antitumor efficacy in hepatocellular carcinoma.

http://www.wikidata.org/entity/Q35955387

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

A novel Golgi protein (GOLPH2) ...... y in hepatocellular carcinoma.

@ast

A novel Golgi protein (GOLPH2) ...... y in hepatocellular carcinoma.

@en

type

label

A novel Golgi protein (GOLPH2) ...... y in hepatocellular carcinoma.

@ast

A novel Golgi protein (GOLPH2) ...... y in hepatocellular carcinoma.

@en

prefLabel

A novel Golgi protein (GOLPH2) ...... y in hepatocellular carcinoma.

@ast

A novel Golgi protein (GOLPH2) ...... y in hepatocellular carcinoma.

@en

P1433

Q35955387-AC45B0A1-13CD-4217-9EDA-B92BCCD9F345

P1476

Q35955387-D471967F-8797-47E1-9983-DFDFD9E3D748

P2093

Q35955387-1ADCE0D4-6DC9-497D-B6A6-757C7BF55511

Q35955387-1F2A8997-6B91-4A0B-96B4-9B241496115D

Q35955387-2DA82F42-58E5-416A-82BC-20AF48829CD5

Q35955387-4F4C65C9-7EA3-4FBB-AA14-30118A5E8478

Q35955387-4F6C1837-F3B8-4A1F-B1A2-942A06295876

Q35955387-504523D8-87AB-4EC9-B6DB-66666A014583

Q35955387-7DAD4806-E482-4966-A026-3FE9A79FD33E

Q35955387-88C751A9-AE8E-44E4-A4C5-278251367A2D

Q35955387-BE6B69B4-B8D1-4F85-ABFA-C4E0B29426FC

Q35955387-D2BBA2C7-84E5-417C-94F3-F115F93DA7FD

P2860

Q35955387-1D2438ED-32A2-4E59-829F-7BBF5AC99297

Q35955387-2CF904C3-5589-4E18-9697-1901EE43F7A6

Q35955387-30EB72B2-F4AA-4202-B554-997DC80CA83D

Q35955387-49C343C3-2263-401B-9076-243B64C6F5C3

Q35955387-4A70E7FD-CFA8-4AD8-89C8-8C0E664738E4

Q35955387-56542F02-AD93-497E-B4E3-EFBD651E848D

Q35955387-59C4AF28-2759-4213-A3FA-A201E8D55C3B

Q35955387-62D8375C-BA5B-4497-A82E-158E307135E5

Q35955387-6D31BF50-85F3-4EEB-B768-4E8F478A5EC1

Q35955387-85CE771E-E62F-48E7-BB1D-082161789461

P304

Q35955387-DC163AC9-7803-4743-9230-ED12F156B07C

P31

Q35955387-79853FD1-F6F9-4EFD-9437-47396902B630

P356

Q35955387-441489D1-63B8-4BF4-8768-8EB10A4F96B9

P407

Q35955387-246FE898-E5CE-4861-8307-4E30408738D9

P433

Q35955387-B92DD7B2-6B81-47F0-AA2B-3A9C90078095

P478

Q35955387-EEAC568A-B34F-4002-903B-440CA8D2E29F

P577

Q35955387-A1DC1330-DC9D-40B5-8A06-2D817885267A

P5875

Q35955387-03C1CB74-54A2-46BF-9E80-30EB5AB745B6

P698

Q35955387-FCB79B7F-B3A7-47C2-ACBA-B7A3877F1700

P921

Q35955387-A1A2B1A2-1BFA-47AB-B882-23B88E2B0724

Q35955387-F5692FCE-3FC0-4E41-A911-D60470D5AF27

P932

Q35955387-5AB4175D-87B4-46A5-A5E8-34C5B79D0789

P356

ONCOTARGET.3769

P1433

P1476

A novel Golgi protein (GOLPH2) ...... y in hepatocellular carcinoma.

@en

P2093

Buyun Ma

http://www.w3.org/2001/XMLSchema#string

Caixia Cui

http://www.w3.org/2001/XMLSchema#string

Fang Huang

http://www.w3.org/2001/XMLSchema#string

Hongfang Zhao

http://www.w3.org/2001/XMLSchema#string

Kan Chen

http://www.w3.org/2001/XMLSchema#string

Panpan Huang

http://www.w3.org/2001/XMLSchema#string

Rong Zhang

http://www.w3.org/2001/XMLSchema#string

Tao Liu

http://www.w3.org/2001/XMLSchema#string

Xinyuan Liu

http://www.w3.org/2001/XMLSchema#string

Xiumei Zhou

http://www.w3.org/2001/XMLSchema#string

P2860

Potent antitumor activity of double-regulated oncolytic adenovirus-mediated ST13 for colorectal cancer.

The predictive value of Golgi protein 73 in differentiating benign from malignant liver tumors

An adenovirus mutant that replicates selectively in p53-deficient human tumor cells.

Serum GP73, a marker for evaluating progression in patients with chronic HBV infections.

GP73 is upregulated by hepatitis C virus (HCV) infection and enhances HCV secretion.

Targeted Hsp70 expression combined with CIK-activated immune reconstruction synergistically exerts antitumor efficacy in patient-derived hepatocellular carcinoma xenograft mouse models.

Targeting Gene-Viro-Therapy with AFP driving Apoptin gene shows potent antitumor effect in hepatocarcinoma

Anti-angiogenic therapy increases intratumoral adenovirus distribution by inducing collagen degradation.

Targeting gene-virotherapy of cancer.

GP73 is down-regulated in gastric cancer and associated with tumor differentiation.

P304

13564-13578

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.3769

http://www.w3.org/2001/XMLSchema#string

P407

P433

15

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2015-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

276922916

http://www.w3.org/2001/XMLSchema#string

P698

25980438

http://www.w3.org/2001/XMLSchema#string

P921

oncolytic virus

P932

4537034

http://www.w3.org/2001/XMLSchema#string